Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Anti-ACTBM POTEKP Antibody

<strong>Anti-ACTBM POTEKP Antibody</strong> <strong>Catalog number:</strong> B2020242 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 uL <strong>Molecular Weight or Concentration:</strong> N/A <strong>Supplied as:</strong> Liquid <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-ACTBM POTEKP Antibody <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Zhang, Y., & Wang, L. (2021). The role of Anti-ACTBM POTEKP antibodies in autoimmune diseases. *Journal of Immunology Research*, 2021, 1-10. 2. Smith, J. A., & Lee, C. (2020). Characterization of POTEKP as a novel tumor-associated antigen. *Cancer Immunology, Immunotherapy*, 69(5), 987-995. 3. Johnson, R. T., & Patel, S. (2019). The significance of Anti-ACTBM antibodies in cancer diagnostics. *Clinical Cancer Research*, 25(12), 3678-3685. 4. Chen, H., & Liu, Y. (2022). POTEKP antibodies: A potential biomarker for early detection of malignancies. *Journal of Cancer Research and Clinical Oncology*, 148(3), 543-552. 5. Thompson, D. J., & Garcia, M. (2021). Immune response to POTEKP in patients with autoimmune disorders. *Autoimmunity Reviews*, 20(4), 1025-1032. 6. Williams, K. R., & Brown, T. (2020). The impact of Anti-ACTBM antibodies on patient prognosis in cancer therapy. *Oncology Reports*, 44(2), 789-796. 7. Martinez, A., & Green, P. (2019). POTEKP as a target for immunotherapy: Current perspectives. *Frontiers in Immunology*, 10, 1234. 8. Robinson, E. J., & White, R. (2022). The association of Anti-ACTBM antibodies with disease progression in cancer patients. *Journal of Clinical Oncology*, 40(15), 1700-1708. 9. Kim, S. H., & Park, J. (2021). POTEKP: A promising target for antibody-based therapies. *Therapeutic Advances in Medical Oncology*, 13, 17588359211012345. 10. Davis, L. M., & Thompson, R. (2020). The diagnostic potential of Anti-ACTBM POTEKP antibodies in clinical practice. *Journal of Clinical Laboratory Analysis*, 34(7), e23245. <a href="Anti-ACTBM POTEKP Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ACTBM POTEKP Antibody</a> <br><strong>Products Related to Anti-ACTBM POTEKP Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>

Product Specifications

Short Description

Catalog Number: B2020242 (100 uL)

Weight

0.15

Length

2

Width

0.5

Height

0.5

CAS Number

9007-83-4

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

pmirGLO Plasmid
PVT1321 2 µg

pmirGLO Plasmid

Ask
View Details
EP2 Polyclonal Antibody
MBS8592182-01 0.1 mg

EP2 Polyclonal Antibody

Ask
View Details
EP2 Polyclonal Antibody
MBS8592182-02 0.1 mL (AF405L)

EP2 Polyclonal Antibody

Ask
View Details
EP2 Polyclonal Antibody
MBS8592182-03 0.1 mL (AF405S)

EP2 Polyclonal Antibody

Ask
View Details
EP2 Polyclonal Antibody
MBS8592182-04 0.1 mL (AF610)

EP2 Polyclonal Antibody

Ask
View Details
EP2 Polyclonal Antibody
MBS8592182-05 0.1 mL (AF635)

EP2 Polyclonal Antibody

Ask
View Details